Home › Funds › Avoro Capital Advisors LLC › KRYS
Avoro Capital Advisors LLC position in KRYS
KRYSTAL BIOTECH INC · Health Care
Avoro Capital Advisors LLC reported holding 2,888,888 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$960.7M, representing 9.94% of its reported portfolio and ranking #3 among its reported holdings. Avoro Capital Advisors LLC has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's KRYS position evolved
Avoro Capital Advisors LLC first disclosed a stake in KRYS in Q3 2023 at 2,565,555 shares (US$297.6M). The position peaked in Q2 2026 at 2,888,888 shares, worth US$1.07B. Across 13 filings, Avoro Capital Advisors LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,888,888 shares valued at US$960.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.57M | $297.60M | New |
| Q4 2023 | 2.57M | $318.28M | Hold |
| Q1 2024 | 2.56M | $454.71M | Hold |
| Q2 2024 | 2.43M | $446.80M | Reduce |
| Q3 2024 | 2.62M | $477.32M | Add |
| Q4 2024 | 2.63M | $411.83M | Hold |
| Q1 2025 | 2.73M | $492.40M | Add |
| Q2 2025 | 2.66M | $365.64M | Reduce |
| Q3 2025 | 2.78M | $490.36M | Add |
| Q4 2025 | 2.89M | $712.23M | Add |
| Q1 2026 | 2.89M | $746.26M | Hold |
| Q2 2026 | 2.89M | $1.07B | Hold |
| Q3 2026 | 2.89M | $960.73M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KRYS and 13F data
KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 41 other funds we track also report a position in KRYS — the largest reported positions include Soleus Capital Management, L.P. (US$349.1M), Redmile Group, LLC (US$234.9M), Hood River Capital Management LLC (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KRYS
- Soleus Capital Management, L.P. 939.25K sh · $349.09M · Q2 2026
- Redmile Group, LLC 632.00K sh · $234.90M · Q2 2026
- Hood River Capital Management LLC 671.99K sh · $223.48M · Q3 2026
- Frazier Life Sciences Management, L.P. 481.31K sh · $178.89M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 520.92K sh · $173.24M · Q3 2026
- BRAIDWELL LP 128.97K sh · $47.94M · Q2 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held KRYS?
Avoro Capital Advisors LLC has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Avoro Capital Advisors LLC's current position in KRYS?
As of Q3 2026, Avoro Capital Advisors LLC holds 2.89M shares of KRYS (KRYSTAL BIOTECH INC), valued at $960.73M, representing 9.94% of its reported portfolio and ranking #3.
Has Avoro Capital Advisors LLC been buying or selling KRYS?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC held unchanged its position in KRYS. The position peaked in Q2 2026 at 2.89M shares.
Which other funds hold KRYS?
Other major institutional holders of KRYS include Soleus Capital Management, L.P., Redmile Group, LLC, Hood River Capital Management LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.